Condition
Cutis Laxa
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Recruiting2
Enrolling By Invitation1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07614997Not ApplicableRecruitingPrimary
Effectiveness and Safety of the Ulthera® System for Skin Laxity in the Lower Face, Submentum and Neck
NCT06330350Recruiting
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
NCT06330324Enrolling By Invitation
Reproductive Options in Inherited Skin Diseases
NCT03887208Phase 1Completed
Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells
NCT01293864TerminatedPrimary
Structural Analysis of Human Tissue
NCT01658163Completed
Use of 2-octyl-cyanoacrylate Together With a Self-adhering Mesh
Showing all 6 trials